FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA, Apple Met Many Times in Last 3 Years

[ Price : $8.95]

E-mails obtained through the Freedom of Information Act by MobiHealthNews show a lengthy relationship between FDA and Apple on a n...

CGMP Violations at Chinas Dongying Tiandong

[ Price : $8.95]

FDA warns Chinas Dongying Tiandong Pharmaceutical Co. about CGMP violations in its production of active pharmaceutical ingredients...

PADE Reporting Violations at STI Pharma

[ Price : $8.95]

FDAs Philadelphia District Office warns STI Pharma about postmarketing adverse drug experience reporting violations involving two ...

Industry Improves Drug Postmarketing Requirements Reporting

[ Price : $8.95]

The latest FDA report on the status of drug postmarketing requirements and commitments shows that industry has improved its (on-ti...

Untitled Letter to Dr. PRP America Over Unapproved Device

[ Price : $8.95]

CBER sends San Diego-based Dr. PRP America an untitled letter over the unapproved marketing of its medical device Dr. PRP Kit for ...

Safety Outcomes Committee MAPP Out

[ Price : $8.95]

CDER issues a MAPP on a new Safety Outcomes Trials subcommittee under the Medical Policy Council.

Key Provisions of ClinicalTrials.gov Final Rule

[ Price : $8.95]

Two DLA Piper attorneys outline changes in an HHS final rule expanding the ClinicalTrials.gov database.

AOA Meets with FDA on Opternative Concerns

[ Price : $8.95]

The American Optometric Association says it met with FDA officials to voice concerns about online self-administered vision exams s...

Support for MDUFA 4

[ Price : $8.95]

Four stakeholders voice their support for provisions in the MDUFAS 4 reauthorization agreement.

Annual Report on Postmarketing Requirements

[ Price : $8.95]

Federal Register Notice: FDA posts an annual report on the status of postmarketing requirements and postmarketing commitments.